DICE CRO

Foundation date

01-02-1989

Sector

#Biotechnology / R&D Services

Subsector

Therapeutic areas

DICE is a CRO specialized in data management, statistics & medical writing.We differentiate by our high quality, service oriented delivery and biostatistical knowledge. DICE supports companies in the delivery of Phase1 to Phase 4 studies and rescue studies. We have over 25 years experience in different therapeutic areas, technologies and target groups. We have succesfully worked together with several pharmaceuticals start-ups from phase 1 until market launch and defended their studies for FDA.

Upcoming events

Latest news

  • reMYND’s ReS19-T program, managing calcium homeostasis for Alzheimer’s, has moved to MAD phase after demonstrating strong safety in SAD phase

    Thursday October 21st 2021

  • Mithra announces Estelle® launch in Belgium

    Thursday October 21st 2021

  • Biotalys awarded multi-year grant to develop new biological solutions for cowpea and other legumes

    Wednesday October 20th 2021